Dan Budwick News Today

SAN FRANCISCO, June 05, 2024 -- Structure Therapeutics Inc. , a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary...

CAMBRIDGE, Mass., May 30, 2024 -- Beam Therapeutics Inc. , a biotechnology company developing precision genetic medicines through base editing, today announced that Giuseppe Ciaramella, president...

SAN FRANCISCO and WALTHAM, Mass., May 23, 2024 (GLOBE NEWSWIRE) -- Apogee Therapeutics, Inc. (NASDAQ:APGE), a clinical-stage biotechnology company advancing differentiated biologics for the treatment of atopic

SAN DIEGO--(BUSINESS WIRE)--May 22, 2024--

CAMBRIDGE, Mass., May 21, 2024 -- Relay Therapeutics, Inc. , a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and...

CAMBRIDGE, Mass., May 21, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (NASDAQ:RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and

Dosing Completed for Sentinel Cohort of BEACON Phase 1/2 Trial of BEAM-101 in Severe Sickle Cell Disease; Expansion Cohort Initiated Clinical Trial Authorisation Application Cleared for the Phase...

CAMBRIDGE, Mass., April 18, 2024 -- Agios Pharmaceuticals, Inc. , a leader in cellular metabolism and PK activation pioneering therapies for rare diseases, today announced the company will host a...

-- State-of-the-art neoantigen prediction platform now predicts HLA Class I presentation of epitopes with

EMERYVILLE, Calif., April 01, 2024 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to dev...